Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.
Also Known As:
Hunter Syndrome; Hunter's Syndrome; Hunter Syndrome Gargoylism; I2S Deficiency; Mucopolysaccharidosis 2; Mucopolysaccharidosis Type 2; Mucopolysaccharidosis Type II; Deficiency, I2S; Deficiency, Iduronate 2-Sulfatase; Deficiency, Iduronate Sulfatase; Deficiency, Sulfoiduronate Sulfatase; Hunters Syndrome; Iduronate 2 Sulfatase Deficiency; Syndrome, Hunter; Syndrome, Hunter's; Gargoylism, Hunter Syndrome; Iduronate 2-Sulfatase Deficiency; Iduronate Sulfatase Deficiency; Sulfoiduronate Sulfatase Deficiency